2 Novel Treatments For Retinitis Pigmentosa Move Closer To Clinical Trials

Two recent experimental treatments – one involving skin-derived induced pluripotent stem (iPS) cell grafts, the other gene therapy – have been shown to produce long-term improvement in visual function in mouse models of retinitis pigmentosa (RP), according to the Columbia University Medical Center (CUMC) scientists who led the studies…
Source: Eye Health / Blindness News